Dr. Isla S MacKenzie

Clinical Senior Lecturer in Clinical Pharmacology

Address:

Medicines Monitoring Unit (MEMO)
Level 7
Ninewells Hospital and Medical School
Dundee
DD1 9SY

Phone Number:

+(44) 01382 383119

Email Address:

isla@memo.dundee.ac.uk

Biography

Dr Isla Mackenzie MBChB (Honours) PhD FRCP Edin is a Clinical Senior Lecturer in Clinical Pharmacology and Honorary Consultant Physician at the University of Dundee and Ninewells Hospital, Dundee.  Research interests include cardiovascular safety of drugs, clinical trials, hypertension and technology in research.

Clinical interests include general medicine, hypertension and adrenal disorders including phaeochromocytoma. Dr Mackenzie trained in Clinical Pharmacology in Cambridge prior to moving to Dundee in 2008.

Dr Mackenzie is a member of the British Hypertension Society Executive Committee, Honorary Secretary of the Scottish Society of Physicians and is Specialty Adviser in Clinical Pharmacology for Scotland.

Research

Dr Mackenzie’s research focuses on improving cardiovascular outcomes and drug safety using a combination of large multicentre randomised clinical trials and pharmacoepidemiological approaches to answer important clinical research questions. She is also interested in clinical trial methodology and improving patient and physician engagement in clinical research.  She is Chief Investigator of the ALL-HEART study (involving 200 GP sites and 5,215 patients) and Principal Investigator of several other studies including FAST and FOURIER.

Swine flu (H1N1 Influenza A) vaccine safety study – an academic post-marketing surveillance study of the safety of swine flu vaccination in the UK population. Collaboration with Drug Safety Research Unit, Southampton /University of Plymouth. (Chief Investigator).

Spironolactone and breast cancer – a pharmacoepidemiological study in the General Practice Research Database (GPRD) investigating whether there is a link between exposure to aldosterone antagonists and increased incidence of breast cancer. Collaboration with Dundee Cancer Centre. (Principal Investigator).

The Standard care versus Celecoxib Outcome Trial (SCOT) – a large multicentre streamlined safety study comparing the cardiovascular and gastrointestinal safety of celecoxib and traditional NSAIDs in patients with osteoarthritis or rheumatoid arthritis. Collaboration with Universities of Aberdeen, Edinburgh, Glasgow, Nottingham, Birmingham and Southern Denmark (Steering Committee Member).

Febuxostat versus Allopurinol Streamlined Trial (FAST)  - a prospective, randomised, open-label, blinded endpoint (PROBE) clinical trial evaluating long term cardiovascular safety of febuxostat in comparison with allopurinol in patients with chronic symptomatic hyperuricaemia. (Principal Investigator and Steering Committee Member).

BHS Prevention And Treatment of Hypertension With Algorithm Based Therapy (PATHWAY) Studies – a series of three clinical trials investigating rational treatment algorithms for hypertension. Collaboration with Universities of Cambridge, Leicester, Edinburgh, Glasgow, Exeter, Manchester, Birmingham, Imperial College and St Bartholomew’s, London. (Steering Committee Member)

Hypertension due to Conn’s adenoma - the localisation of adrenal cortical adenomas by 11C-metomidate PET scanning following dexamethasone and fludrocortisone suppression. Collaboration with University of Cambridge (Co-Investigator).

Personal health monitoring through mobile devices - Collaboration with Herriot-Watt University, University of Stirling and Glasgow School of Art. (Co-Investigator).

Effervescent medications, sodium content and blood pressure - Pharmacoepidemiological study investigating the effect of chronic therapy with effervescent tablets containing high levels of sodium and risk of hypertension and cardiovascular events.

‘Get Randomised’ Campaign – methods of engaging the public in clinical research. Highly Commended entry for Ian Stevenson Prize for Public Engagement, University of Dundee, 2010.

Further Cardiovascular Outcomes Research with PCSK9 Inhibition Subjects with Elevated Risk (FOURIER) – a multicentre randomised trial of LDL-lowering in patients at high cardiovascular risk (Principal Investigator).

Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART) – a prospective, randomised, open-label, blinded endpoint (PROBE) clinical trial evaluating whether Allopurinol improves cardiovascular outcomes in patients with ischaemic heart disease (Chief Investigator and Steering Committee Member).

Publications

Teaching

Medicine, Clinical Pharmacology and Therapeutics teaching:

Undergraduate teaching

  • Lectures, seminars, bedside teaching in Clinical Pharmacology/Therapeutics and Medicine (2000 - present)
  • Marking and question writing for University of Dundee medical student examinations (2008 - present)
  • Medical School Interviews, University of Dundee (2011 - present)
  • Clinical Supervisor - MBPhD students (2000 - 2008)
  • Clinical Pharmacology college supervisions, Cambridge (2000 - 2004)
  • Clinical School Admission Interviews, University of Cambridge (2002 - 2008)
  • Year 5 Theme SSC: The Science Behind Prescribing (M-5089) (2013-)

Postgraduate and multidisciplinary teaching

  • MRCP (PACES) teaching, Tayside (2012 - present)
  • Educational Supervisor, General Medicine (2012 - present)
  • Ward-based and clinical simulator teaching, Cambridge graduate course (2006 - 2008)
  • PASTEST Lecturer in Clinical Pharmacology, London (2005 - 2008)
  • Bank Physician Trainer for GSK, Cambridge (2005 - 2008)
  • Member of Clinical Pharmacology Training Committee, Cambridge (2000 - 2005)
  • Contributor to Clinical Pharmacology section of Medical Masterclass Website, Royal College of Physicians London / Blackwell Publishing (2003 - present)

Teaching Courses:

  • PGCertMedEd (distance learning) – completed 2013, University of Dundee
  • Team Based Learning Workshop, June 2013
  • Supporting Effective Practice in Postgraduate Supervision workshop, October 2012
  • New SCOTS Educational Supervision Workshop, May 2010
  • Equality and Diversity Training, University of Dundee, Feb 2010. Disability, Disability in the Workplace, Diversity in Learning and Teaching, Stress in the Workplace, A Manager’s Guide to Stress
  • Train the Trainers Teaching Course (2005)

PhD Supervision

Current supervision of research students

PhD students (secondary supervisor) – David Rorie, University of Dundee 2012-

                                                            Lewis McConnachie, University of Dundee 2012-

MD student (secondary supervisor) –    Claudine Jennings, University of Dundee 2012-

Conferences

Forthcoming invited lectures:

  • Hypertension. Tayside Pharmacists’ Meeting, March 2014.

Invited Lectures:

  • Cardiovascular risk and rheumatological disease: The Watson Buchanan Lecture, Scottish Society of Rheumatology meeting, November 2013.
  • Spironolactone – is it time to license it for hypertension in the UK? Caledonian Society of Clinical Pharmacology Meeting, Edinburgh, November 2013.
  • Presenting research using posters. Dundee Research and Academic Medicine Society (DRAMS) Meeting, Dundee, October 2013.
  • Phaeochromocytoma: update on genetics - Diabetes and Endocrinology Meeting, Dundee, June 2013.
  • SHARP Tayside Meeting. Management of hypertension - as easy as ACD. Dundee, May 2013.
  • FAST abstracts. FAST Steering Committee Meeting, Edinburgh, May 2013.
  • Update on catecholamine secreting tumours. Endocrinology Meeting, Aberdeen, November 2012.
  • Gout and the FAST study. Tayside Rheumatology Meeting, Dundee, October 2012.
  • Use of record linkage in clinical trials. Scottish Health Informatics Programme (SHIP) Conference: Exploiting Existing Data for Health Research, St Andrews, September 2011.
  • NSAID update. SCOT Steering Committee Meeting, Edinburgh, February 2011.
  • Swine flu vaccination: a safety study. CMDN Research Symposium, Dundee, January 2011.
  • Trial logistics and recruitment: likely challenges. FAST Steering Committee Meeting, London, December 2010.
  • The Standard care versus Celecoxib Outcome Trial. UKPCRN National Team Day, Birmingham, November 2010.
  • Clinical management of phaeochromocytoma. Endocrinology 2010, London, September 2010.
  • Novel uses of technologies in clinical trials. Society for Clinical Trials Annual Conference, Baltimore, United States, May 2010.
  • Swine flu vaccine safety study - pilot of the use of novel technologies to collect safety data. Caledonian Society of Clinical Pharmacology Annual Meeting, Glasgow, March 2010.
  • Advances in catecholamine-secreting tumours. RCPE Tayside Symposium, February 2010.
  • NSAIDs and cardiovascular disease. SCOT Principal Investigator Meeting, Copenhagen, Denmark, May 2009.
  • Accelerated hypertension. Acute Medicine Meeting, Ninewells Hospital, April 2009.
  • Phaeochromocytoma. Grand Round, Western Infirmary, Glasgow, March 2009.
  • Update on NSAIDs and cardiovascular disease. SCOT Steering Committee Meeting, Edinburgh, February 2009.
  • Adrenal incidentaloma. Diabetes & Endocrinology Meeting, Ninewells Hospital, February 2009.
  • Keynote lecture. Cardiovascular safety of drugs: the ‘real life’ collaborative approach in Scotland. Scottish Cardiovascular Forum, Inverness, January 2009.
  • Phaeochromocytoma. Endocrinology Meeting, Aberdeen Royal Infirmary, January 2009.